InfuSystems Holdings, Inc. (INFU) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
About InfuSystems Holdings, Inc.
InfuSystems Holdings, Inc. is led by CEO Carrie A. Lachance, employs 502 people, headquartered in US, publicly traded since 2007.
InfuSystems Holdings, Inc. (INFU) stock trades at $13.94 with a market capitalization of $277.65M. The stock is valued at a price-to-earnings (P/E) ratio of 31.31, price-to-book of 4.48, price-to-sales of 1.85. Over the past 52 weeks the stock has ranged between $7.29 and $14.23, and currently trades 2.0% below its 52-week high.
On profitability, InfuSystems Holdings, Inc. generates a return on equity (ROE) of 14.81%, return on capital employed of 16.10%, an operating margin of 8.39%, a net profit margin of 5.96%.
InfuSystems Holdings, Inc. by the numbers, 2016–2025
Between 2016 and 2025 InfuSystems Holdings, Inc. reported revenue of $70.0M rising to $143.0M, a change of +104.3% across 10 years. Compounded, revenue has grown 8.1% a year over five years, 9.1% over three, 5.9% over the last twelve months. Net profit was $7.0M in 2025.
Operating margin went from 1.4% in 2016 to 8.3% in 2025, a gain of 6.9 percentage points. The most recent net margin is 5.96%. On a trailing twelve-month basis to Jun '26, revenue is $143.0M and net profit $8.0M.
Borrowings fell from $37.0M to $3.0M, cash from operations was $24.0M in the latest year, positive in 10 of the last 10.
Return on equity has averaged 4.0% over five years, and was 12.3% in the most recent year.
The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
InfuSystems Holdings, Inc. (INFU) — frequently asked questions
What is InfuSystems Holdings, Inc. (INFU) stock price today?
InfuSystems Holdings, Inc. (INFU) is currently trading at $13.94, down 1.41% today.
What is INFU P/E ratio?
InfuSystems Holdings, Inc.'s P/E ratio is 31.31. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is INFU return on equity (ROE)?
InfuSystems Holdings, Inc.'s return on equity (ROE) is 14.81%. ROE measures net income relative to shareholders' equity. This is within the typical market range of roughly 12-15%.
What is InfuSystems Holdings, Inc.'s market cap?
InfuSystems Holdings, Inc. has a market capitalization of $277.65M.
Does INFU pay a dividend?
InfuSystems Holdings, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does INFU carry?
InfuSystems Holdings, Inc. has a debt-to-equity ratio of 0.39. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is INFU's profit margin?
InfuSystems Holdings, Inc. reports a net profit margin of 5.96% — the share of revenue left after every cost, including tax and interest.
What sector is INFU in?
InfuSystems Holdings, Inc. is classified under Healthcare, in the Medical - Instruments & Supplies industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is INFU listed on?
InfuSystems Holdings, Inc. trades on ASE under the ticker INFU.
What is INFU's 52-week range?
Over the last year InfuSystems Holdings, Inc. has traded between $7.29 and $14.23.
Related Healthcare Stocks
Popular Stocks
Screens INFU currently matches
On the figures above, InfuSystems Holdings, Inc. passes the filters for 1 of our ready-made screens, among them Micro Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.